Latest debt-to-equity ratio
Latigo Biotherapeutics Debt-to-equity ratio
Direct answer
Latigo Biotherapeutics's debt-to-equity ratio is 249.96%.
The verified market snapshot reports 249.96%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 16, 2026.
Get free Latigo Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 249.96%